Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Results Conference Call February 22, 2024 4:30 PM ET Company Participants Sasha Damouni Ellis - Executive Vice President, Chief Corporate Affairs Officer Marianne De Backer - Chief Executive Officer Phil Pang - Chief Medical Officer Sung Lee - Chief Financial Officer Conference Call Participants Nik Gasic - Leerink Partners Eva Privitera - TD Cowen Patrick Trucchio - H.C. Wainwright Eric Joseph - JP Morgan Alec Stranahan - Bank of America Joseph Stringer - Needha ...